0.00
100.00%
-64.97
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt ALPN?
Forum
Prognose
Aktiensplit
Alpine Immune Sciences Inc Aktie (ALPN) Neueste Nachrichten
MyMyasthenia Gravis Clinical Trial Analysis, 2024 Updates | - openPR
Big Drugmakers Are Clinching Smaller Deals - The Wall Street Journal
Big Drugmakers Are Clinching Smaller Deals - Yahoo Finance
Alpine (ALPN) Surges 37% on $4.9B Buyout Offer From Vertex - MSN
Vertex Lifts Revenue Outlook on Growth of Cystic Fibrosis Drugs - Bloomberg
Vertex Pharma raises annual revenue forecast on strong demand for its cystic fibrosis treatments - Yahoo Finance
Vertex Pharmaceuticals Moves Beyond $10B Cystic Fibrosis Franchise, Pays Around $5B For Kidney Disease Player Alpine Immune - MSN
Vertex enters into a definitive agreement to acquire Alpine Immune Sciences - World Business Outlook
Even though Alpine Immune Sciences (NASDAQ:ALPN) has lost US$39m market cap in last 7 days, shareholders are still up 200% over 3 years - Yahoo New Zealand News
Fastest Growing Public Companies in Washington State - The Business Journals
Vertex Pharmaceuticals reports $4.4 billion R&D expense post-acquisition - Investing.com
Even though Alpine Immune Sciences (NASDAQ:ALPN) has lost US$39m market cap in last 7 days, shareholders are ... - Yahoo New Zealand News
Has SiBone (SIBN) Outpaced Other Medical Stocks This Year? - Yahoo Lifestyle Singapore
Esperion Therapeutics (ESPR) Moves 6.5% Higher: Will This Strength Last? - Yahoo Lifestyle Singapore
Here's Why You Should Invest in Alpine (ALPN) Stock Now - Yahoo Lifestyle UK
Alpine Immune Sciences (NASDAQ:ALPN) jumps 12% this week, taking three-year gains to 96% - Yahoo Sport Australia
Biopharma index outpaces market benchmarks with an 8% rise - BioWorld Online
Alpine Immune Sciences, Inc. (ALPN) Reports Q4 Loss, Tops Revenue Estimates - Yahoo Sport Australia
Alpine Immune Sciences, Inc. (ALPN) Reports Q1 Loss, Tops Revenue Estimates - Yahoo Movies UK
Alpine Immune Sciences And Abbvie Announce Option And License Agreement For Development And Commercialization Of ALPN-101 - Reuters
Biogen’s HI-Bio Buy Is Latest Biopharma Spending Spree in Projected $257B Immunology Market - BioSpace
Rafferty Asset Management LLC Purchases Shares of 80162 Alpine Immune Sciences, Inc. (NASDAQ:ALPN) - Defense World
Alpine Immune Sciences, Inc. (NASDAQ:ALPN) Given Consensus Rating of “Hold” by Brokerages - Defense World
Alpine Immune Sciences, Inc. (NASDAQ:ALPN) Shares Bought by Charles Schwab Investment Management Inc. - Defense World
Is a Surprise Coming for Alpine Immune Sciences (ALPN) This Earnings Season? - Yahoo Movies UK
Alpine Immune Sciences, Inc. (ALPN) Moves 9.5% Higher: Will This Strength Last? - Yahoo Singapore News
Swiss National Bank Grows Position in Alpine Immune Sciences, Inc. (NASDAQ:ALPN) - Defense World
Trexquant Investment LP Purchases 25202 Shares of Alpine Immune Sciences, Inc. (NASDAQ:ALPN) - Defense World
Alpine Immune (ALPN) Stock Up 19% MTD, Will the Uptick Continue? - Yahoo Movies UK
Franklin Resources Inc. Acquires Shares of 1220333 Alpine Immune Sciences, Inc. (NASDAQ:ALPN) - Defense World
BNP Paribas Financial Markets Has $2.04 Million Stock Position in Alpine Immune Sciences, Inc. (NASDAQ:ALPN) - MarketBeat
BNP Paribas Financial Markets Buys 93423 Shares of Alpine Immune Sciences, Inc. (NASDAQ:ALPN) - Defense World
Alpine Immune Sciences, Inc. (ALPN) Reports Q3 Loss, Misses Revenue Estimates - Yahoo Lifestyle Australia
Vertex Pharma's $4.9 billion takeover of Alpine Immune gives it access to a potential billion-dollar franchise, analyst says - MSN
Fenwick Represents Alpine Immune Sciences in its Acquisition by Vertex Pharmaceuticals - Fenwick & West LLP
How To Trade (ALPN) - Stock Traders Daily
Jump Financial LLC Takes Position in Alpine Immune Sciences, Inc. (NASDAQ:ALPN) - MarketBeat
Alpine Immune jumps on report of takeover interest - MSN
Jump Financial LLC Invests $1.06 Million in Alpine Immune Sciences, Inc. (NASDAQ:ALPN) - Defense World
Alpine Immune Sciences, Inc. (NASDAQ:ALPN) Shares Acquired by New York State Common Retirement Fund - Defense World
Wedbush Reiterates "Neutral" Rating for Alpine Immune Sciences (NASDAQ:ALPN) - MarketBeat
Alpine Immune Sciences, Inc. (NASDAQ:ALPN) Receives Consensus Rating of "Hold" from Brokerages - MarketBeat
What 11 Analyst Ratings Have To Say About Alpine Immune SciencesAlpine Immune Sciences (NASDAQ:ALPN) - Benzinga
What 11 Analyst Ratings Have To Say About Alpine Immune Sciences - Quantisnow
Alpine Immune Sciences (NASDAQ:ALPN) Reaches New 12-Month High at $64.96 - MarketBeat
Alpine Immune Sciences, Inc. (NASDAQ:ALPN) Sees Significant Drop in Short Interest - MarketBeat
Alpine Immune Sciences, Inc. (ALPN) Earnings Expected to Grow: What to Know Ahead of Q3 Release - Yahoo Movies UK
Alpine Immune Sciences (NASDAQ:ALPN) Sees Strong Trading Volume - Defense World
Strength Seen in Alpine Immune Sciences, Inc. (ALPN): Can Its 7.5% Jump Turn into More Strength? - Yahoo Lifestyle UK
Alpine Immune Sciences Inc (ALPN) Reports Q1 2024 Financials Amid Pending Acquisition by Vertex ... - Yahoo Finance
Alpine Immune stock ticks higher as HSR waiting period for Vertex Pharma deal expires - Seeking Alpha
Alpine Immune Sciences Communicates Key Updates RegularlyTipRanks.com - TipRanks
Alpine Immune Sciences Reports First Quarter 2024 Financial Results - Business Wire
Alpine Immune Sciences, Inc. (NASDAQ:ALPN) Position Cut by Vivo Capital LLC - MarketBeat
Alpine Immune Sciences (NASDAQ:ALPN) Sets New 52-Week High at $64.72 - MarketBeat
Alpine Immune Sciences (NASDAQ:ALPN) shareholders have earned a 20% CAGR over the last five years - Yahoo Movies UK
Zevra Therapeutics (ZVRA) Reports Q1 Loss, Lags Revenue Estimates - Zacks Investment Research
Zurcher Kantonalbank Zurich Cantonalbank Makes New Investment in Alpine Immune Sciences, Inc. (NASDAQ:ALPN) - Defense World
Great news for Alpine Immune Sciences, Inc. (NASDAQ:ALPN): Insiders acquired stock in large numbers last year - Yahoo Sport Australia
Alpine Immune Sciences, Inc. (ALPN) Reports Q3 Loss, Misses Revenue Estimates - Yahoo Movies Canada
Vertex's (VRTX) Q1 Earnings Beat, Trikafta Drives Sales - Zacks Investment Research
Here's Why You Should Invest in Alpine (ALPN) Stock Now - Yahoo News UK
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Kapitalisierung:
|
Volumen (24h):